These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8845065)

  • 1. Gadolinium-enhanced breast MRI.
    Kelcz F; Santyr G
    Crit Rev Diagn Imaging; 1995; 36(4):287-338. PubMed ID: 8845065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear magnetic resonance in the diagnosis of breast cancer.
    Turner DA; Alcorn FS; Adler YT
    Radiol Clin North Am; 1988 May; 26(3):673-87. PubMed ID: 3287440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging of the breast with Gd-DTPA enhancement: comparison with mammography and ultrasonography.
    Hachiya J; Seki T; Okada M; Nitatori T; Korenaga T; Furuya Y
    Radiat Med; 1991; 9(6):232-40. PubMed ID: 1668410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
    Stomper PC; Herman S; Klippenstein DL; Winston JS; Edge SB; Arredondo MA; Mazurchuk RV; Blumenson LE
    Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Focal and diffuse lesions in dynamic MR-mammography of healthy probands].
    Kuhl CK; Seibert C; Sommer T; Kreft B; Gieseke J; Schild HH
    Rofo; 1995 Sep; 163(3):219-24. PubMed ID: 7548868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadopentetate dimeglumine-enhanced chemical-shift MR imaging of the breast.
    Rubens D; Totterman S; Chacko AK; Kothari K; Logan-Young W; Szumowski J; Simon JH; Zachariah E
    AJR Am J Roentgenol; 1991 Aug; 157(2):267-70. PubMed ID: 1853803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The feasibility of magnetic resonance tomography in the diagnosis of non-palpable breast tumors].
    Zapf S; Halbsguth A; Brunier A; Mitze M; Klemencic J; Wilhelm K
    Rofo; 1991 Jan; 154(1):106-10. PubMed ID: 1846678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions.
    den Boer JA; Hoenderop RK; Smink J; Dornseiffen G; Koch PW; Mulder JH; Slump CH; Volker ED; de Vos RA
    J Magn Reson Imaging; 1997; 7(4):702-15. PubMed ID: 9243392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Technics for the preoperative marking of nonpalpable breast lesions in MRT].
    Sittek H; Kessler M; Müller-Lisse U; Untch M; Bohmert H; Reiser M
    Rofo; 1996 Jul; 165(1):84-7. PubMed ID: 8765369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging of the breast after surgery for breast cancer.
    Whitehouse GH; Moore NR
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):591-603. PubMed ID: 7489311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions.
    Boné B; Péntek Z; Perbeck L; Veress B
    Acta Radiol; 1997 Jul; 38(4 Pt 1):489-96. PubMed ID: 9240665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast.
    Nunes LW; Schnall MD; Siegelman ES; Langlotz CP; Orel SG; Sullivan D; Muenz LA; Reynolds CA; Torosian MH
    AJR Am J Roentgenol; 1997 Aug; 169(2):409-15. PubMed ID: 9242744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MR imaging for breast cancer].
    Seki T; Hachiya J; Nitatori T; Yokoyama K; Fukushima H; Uchigasaki S
    Nihon Geka Gakkai Zasshi; 1996 May; 97(5):347-56. PubMed ID: 8709936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique.
    Boetes C; Barentsz JO; Mus RD; van der Sluis RF; van Erning LJ; Hendriks JH; Holland R; Ruys SH
    Radiology; 1994 Dec; 193(3):777-81. PubMed ID: 7972823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed model of gadolinium enhanced MRI of breast disease.
    Kenney PJ; Sobol WT; Smith JK; Morgan DE
    Eur J Radiol; 1997 Feb; 24(2):109-19. PubMed ID: 9097052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging of thymic epithelial tumors.
    Kushihashi T; Fujisawa H; Munechika H
    Crit Rev Diagn Imaging; 1996 Aug; 37(3):191-259. PubMed ID: 8872410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The MRT of the breast with 2D-spin-echo and gradient-echo sequences in diagnostically problematic cases].
    Allgayer B; Lukas P; Loos W; Kersting-Sommerhoff B
    Rofo; 1993 May; 158(5):423-7. PubMed ID: 8490150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of peripheral enhancement in breast masses: correlation of findings on contrast medium enhanced MRI with histologic features and tumor angiogenesis.
    Buadu LD; Murakami J; Murayama S; Hashiguchi N; Sakai S; Toyoshima S; Masuda K; Kuroki S; Ohno S
    J Comput Assist Tomogr; 1997; 21(3):421-30. PubMed ID: 9135652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
    Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C
    Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model.
    Tofts PS; Berkowitz B; Schnall MD
    Magn Reson Med; 1995 Apr; 33(4):564-8. PubMed ID: 7776889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.